rs121909497
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_002427.4(MMP13):c.224T>C(p.Phe75Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F75L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002427.4 missense
Scores
Clinical Significance
Conservation
Publications
- spondyloepimetaphyseal dysplasia, Missouri typeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- metaphyseal chondrodysplasia, Spahr typeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- metaphyseal anadysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMP13 | NM_002427.4 | c.224T>C | p.Phe75Ser | missense_variant | Exon 2 of 10 | ENST00000260302.8 | NP_002418.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 75 of the MMP13 protein (p.Phe75Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant spondyloepimetaphyseal dysplasia, Missouri type (PMID: 16167086). It has also been observed to segregate with disease in related individuals. This variant is also known as F56S. ClinVar contains an entry for this variant (Variation ID: 9443). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MMP13 protein function. Experimental studies have shown that this missense change affects MMP13 function (PMID: 16167086). For these reasons, this variant has been classified as Pathogenic. -
Spondyloepimetaphyseal dysplasia, Missouri type Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at